Armatura Will Compete for International Galien Award
The Greek nutraceutical firm will represent its Viusid product at the global ceremony in New York this October.
Updated on Oct. 11, 2026 in Healthcare
Live Poll
Should nutraceutical products receive formal recognition alongside conventional medical treatments?
Armatura has secured a nomination for its product Viusid in the international Prix Galien pharmaceutical product category. The company will compete for the global honor at a ceremony held on October 29, 2026.
Why it matters
The recognition highlights the rising prominence of nutraceutical innovation within the broader pharmaceutical industry. For operators, such honors serve as signals for market traction and research validation in specialized product categories.
Armatura is one of 13 global nominees selected for the pharmaceutical product category at the international Prix Galien awards. This follows the firm's win of the Prix Galien Greece Innovative Technology Award in April 2025.
The players
Armatura
A Greek company founded in 2015 that distributes nutraceutical products, including those developed by the Spanish firm Catalysis.
Dimitris Bourlivas
The founder of Armatura who is set to attend the international awards ceremony in New York.
George Chrousos
A medical committee chair who previously selected Viusid as the best nutraceutical in Greece.
The details
Armatura, founded in 2015, distributes nutraceutical products originally developed by the Spanish company Catalysis. Its product Viusid utilizes a combination of pre-activated chemical compounds, including vitamins, antioxidants, and plant extracts. The nomination follows a selection by an international committee of Prix Galien presidents, building on clinical studies that have examined the product's use in managing various viral conditions, including hepatitis and HIV.
Timeline
2015: Armatura was founded.
April 2025: Prix Galien Greece held its award presentation ceremony at the Athens Concert Hall.
October 29, 2026: The international Prix Galien awards ceremony takes place at the American Museum of Natural History in New York.
Market Landscape
The nomination follows Armatura's success at the Prix Galien Greece Innovative Technology Award in 2025. This progression reflects a common industry pattern where companies utilize regional validations as a springboard for global competitive positioning.
Operators in the nutraceutical space should monitor the winning entries at the upcoming ceremony to identify emerging standards in clinical study design and product efficacy reporting. Tracking these global benchmarks can inform future procurement strategies and product development roadmaps.
The takeaway
This nomination signals the increasing integration of nutraceuticals into formal pharmaceutical award pathways. Businesses operating in this space should review the clinical documentation and evidence standards used by nominees to benchmark their own product development pipelines.
What happens next
The international Prix Galien awards ceremony is scheduled for October 29, 2026, at the American Museum of Natural History.
Further reading
For broader trends in industry innovation and regulatory recognition, explore the latest developments in Healthcare.
Source note: This article includes information reported by Greek City Times.
Live Poll
Should nutraceutical products receive formal recognition alongside conventional medical treatments?
